E Venus Pharmaceutical
1 Duncan Dr
Cranbury, NJ 08512
Cornerstone Pharmaceuticals, based in Cranbury, NJ, is dedicated to exploring innovative antimetabolic cancer therapies. The company is currently focused on testing its lead drug candidate, CPI-613 (devimistat), in various preclinical models of cancer.
With a commitment to advancing cancer treatment, Cornerstone Pharmaceuticals aims to develop effective therapeutic combinations that target metabolic pathways in cancer cells. Their research and development efforts are centered on improving patient outcomes through novel therapeutic strategies.
Generated from the website
Also at this address
See a problem?
You might also like
Partial Data by Foursquare.

